|
CLDN12 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.90512000000087E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.962300E-03 |
| Normal-vs-Stage2 |
2.867700E-02 |
| Normal-vs-Stage3 |
8.92400000007676E-07 |
| Normal-vs-Stage4 |
4.6299000000527E-06 |
| Stage1-vs-Stage2 |
7.967400E-01 |
| Stage1-vs-Stage3 |
1.165990E-02 |
| Stage1-vs-Stage4 |
2.034500E-02 |
| Stage2-vs-Stage3 |
1.179620E-01 |
| Stage2-vs-Stage4 |
1.590190E-01 |
| Stage3-vs-Stage4 |
8.366400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.04029999999467E-05 |
| Normal-vs-AfricanAmerican |
3.820300E-04 |
| Normal-vs-Asian |
5.646200E-01 |
| Caucasian-vs-AfricanAmerican |
5.853800E-01 |
| Caucasian-vs-Asian |
4.344000E-02 |
| AfricanAmerican-vs-Asian |
1.579630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.36379999996039E-06 |
| Normal-vs-Female |
3.841500E-03 |
| Male-vs-Female |
2.534200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.856350E-03 |
| Normal-vs-Age(41-60Yrs) |
8.986800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.73904999999364E-05 |
| Normal-vs-Age(81-100Yrs) |
1.360460E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.441600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.767000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.917600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.135600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.587400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.998200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.153440E-01 |
| Normal-vs-Grade 2 |
2.205600E-02 |
| Normal-vs-Grade 3 |
1.16910000003134E-06 |
| Normal-vs-Grade 4 |
8.79329997705014E-09 |
| Grade 1-vs-Grade 2 |
7.688800E-01 |
| Grade 1-vs-Grade 3 |
4.044400E-01 |
| Grade 1-vs-Grade 4 |
6.543800E-02 |
| Grade 2-vs-Grade 3 |
1.791720E-02 |
| Grade 2-vs-Grade 4 |
1.413210E-04 |
| Grade 3-vs-Grade 4 |
2.194400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.900000E-02 |
| Normal-vs-ccB subtype |
3.62219999999747E-05 |
| ccA subtype-vs-ccB subtype |
1.323800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.300110E-03 |
| Normal-vs-N1 |
1.524440E-02 |
| N0-vs-N1 |
4.856400E-01 |
|
|
